To determine if the EGFR kinase activity is essential for EREG-induced PDL1, we examined the roles of EREG in absence or presence of EGFR inhibitors, erlotinib, gefitinib, or AG1478 in HNSCC cells. The gene discussed is EREG; the disease is head and neck squamous cell carcinoma.